Belgium· BE-AMP-SAM541857-00
Besremi 250 µg/0.5 ml
A ropeginterferon alfa-2b product containing ropeginterferon alfa-2b, registered in Belgium by AOP Orphan Pharmaceuticals. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Ropeginterferon alfa-2b is registered in 12 of 19 countries.
Countries holding a registration under ATC L03AB15 (ropeginterferon alfa-2b), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Ropeginterferon alfa-2b · ATC L03AB15
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Ropeginterferon Alfa-2b
- Manufacturer
- AOP Orphan Pharmaceuticals
- Country
- Belgium (BE)
- ATC code
- L03AB15
- ATC class
- Ropeginterferon alfa-2b
- Defined daily dose
- 18 mcg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
1 priced- be_apb4860375EUR 1902.42
- be_apb7741440
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ropeginterferon alfa-2b in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBESREMIAOP Orphan Pharmaceuticals GmbH, Wien
- SwitzerlandBesremi
- SpainBESREMI 250 MICROGRAMOS/0,5 ML DE SOLUCION PARA INYECCION EN PLUMA PRECARGADAAop Orphan Pharmaceuticals Gmbh
- PolandBesremiAOP Orphan Pharmaceuticals GmbH
- SwedenBesremi 250 mikrogram/0,5 ml Injektionsvätska, lösning i förfylld injektionspennaAop Orphan Pharmaceuticals GmbH
- United StatesBESREMiPharmaEssentia USA
- FinlandBesremiOrifarm Oy
- NorwayBesremiAOP Orphan Pharmaceuticals AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Besremi
- Liechtenstein · Besremi
- Norway · Besremi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eae70a1c-ead6-44da-b6d3-8fd07cb8af76 GET /v1/drugs/eae70a1c-ead6-44da-b6d3-8fd07cb8af76?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled pen",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Besremi 250 µg/0.5 ml",
"name_fr": "Besremi 250 µg/0.5 ml",
"name_nl": "Besremi 250 µg/0.5 ml",
"amp_code": "SAM541857-00",
"strengths": [
"500.0000",
"500.0000",
"10.0000",
"10.0000"
],
"pack_count": 2,
"substances": [
"Ropeginterferon Alfa-2b",
"Benzyl Alcohol",
"Sodium Acetate",
"Sodium Chloride",
"Polysorbate 80"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Ropeginterferon Alfa-2b",
"authorisation_numbers": [
"EU/1/18/1352/001",
"EU/1/18/1352/003"
]
}See everything about ropeginterferon alfa-2b.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.